Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed from cells' surface and circulate in soluble form (sTACI). We investigated the impact of serum BLyS and sTACI levels at diagnosis in CLL p...

Full description

Bibliographic Details
Main Authors: Kyrtsonis, Marie-Christine, Sarris, Katerina, Koulieris, Efstathios, Maltezas, Dimitrios, Nikolaou, Eftychia, Angelopoulou, Maria K., Bartzis, Vassiliki, Tzenou, Tatiana, Dimou, Maria, Siakandaris, Mariana P., Viniou, Nora A., Sachanas, Sotirios, Kalpadakis, Christina, Sfikakis, Petros P., Pangalis, Gerassimos A., Panayiotidis, Panayiotis
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138780/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138780/

Similar Items